<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(4)</volume><submitter>Ponomarenko I</submitter><pubmed_abstract>The purpose of this work was to find a link between the breast cancer (BC)-risk effects of sex hormone-binding globulin (SHBG)-associated polymorphisms and obesity. The study was conducted on a sample of 1498 women (358 BC; 1140 controls) who, depending on the presence/absence of obesity, were divided into two groups: obese (119 BC; 253 controls) and non-obese (239 BC; 887 controls). Genotyping of nine SHBG-associated single nucleotide polymorphisms (SNP)-rs17496332 &lt;i>PRMT6&lt;/i>, rs780093 &lt;i>GCKR&lt;/i>, rs10454142 &lt;i>PPP1R21&lt;/i>, rs3779195 &lt;i>BAIAP2L1&lt;/i>, rs440837 &lt;i>ZBTB10&lt;/i>, rs7910927 &lt;i>JMJD1C&lt;/i>, rs4149056 &lt;i>SLCO1B1&lt;/i>, rs8023580 &lt;i>NR2F2&lt;/i>, and rs12150660 &lt;i>SHBG&lt;/i>-was executed, and the BC-risk impact of these loci was analyzed by logistic regression separately in each group o</pubmed_abstract><journal>Biomedicines</journal><pagination>818</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11048332</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Obesity-Dependent Association of the rs10454142 &lt;i>PPP1R21&lt;/i> with Breast Cancer.</pubmed_title><pmcid>PMC11048332</pmcid><pubmed_authors>Pasenov K</pubmed_authors><pubmed_authors>Churnosov V</pubmed_authors><pubmed_authors>Churnosova M</pubmed_authors><pubmed_authors>Ponomarenko M</pubmed_authors><pubmed_authors>Sorokina I</pubmed_authors><pubmed_authors>Aristova I</pubmed_authors><pubmed_authors>Churnosov M</pubmed_authors><pubmed_authors>Reshetnikova Y</pubmed_authors><pubmed_authors>Reshetnikov E</pubmed_authors><pubmed_authors>Ponomarenko I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Obesity-Dependent Association of the rs10454142 &lt;i>PPP1R21&lt;/i> with Breast Cancer.</name><description>The purpose of this work was to find a link between the breast cancer (BC)-risk effects of sex hormone-binding globulin (SHBG)-associated polymorphisms and obesity. The study was conducted on a sample of 1498 women (358 BC; 1140 controls) who, depending on the presence/absence of obesity, were divided into two groups: obese (119 BC; 253 controls) and non-obese (239 BC; 887 controls). Genotyping of nine SHBG-associated single nucleotide polymorphisms (SNP)-rs17496332 &lt;i>PRMT6&lt;/i>, rs780093 &lt;i>GCKR&lt;/i>, rs10454142 &lt;i>PPP1R21&lt;/i>, rs3779195 &lt;i>BAIAP2L1&lt;/i>, rs440837 &lt;i>ZBTB10&lt;/i>, rs7910927 &lt;i>JMJD1C&lt;/i>, rs4149056 &lt;i>SLCO1B1&lt;/i>, rs8023580 &lt;i>NR2F2&lt;/i>, and rs12150660 &lt;i>SHBG&lt;/i>-was executed, and the BC-risk impact of these loci was analyzed by logistic regression separately in each group o</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-05-20T03:16:29.017Z</modification><creation>2026-05-20T03:07:46.945Z</creation></dates><accession>S-EPMC11048332</accession><cross_references><pubmed>38672173</pubmed><doi>10.3390/biomedicines12040818</doi></cross_references></HashMap>